These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 30832674)

  • 21. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
    Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
    J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip.
    Gao L; Yan SB; Yang J; Kong JL; Shi K; Ma FC; Huang LZ; Luo J; Yin SY; He RQ; Hu XH; Chen G
    BMC Med Genomics; 2020 Jan; 13(1):3. PubMed ID: 31906958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
    He RQ; Wu PR; Xiang XL; Yang X; Liang HW; Qiu XH; Yang LH; Peng ZG; Chen G
    Int J Mol Med; 2018 May; 41(5):2813-2831. PubMed ID: 29484429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
    Lu YJ; Liu RY; Hu K; Wang Y
    Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-542-3p exerts tumor suppressive functions in non-small cell lung cancer cells by upregulating FTSJ2.
    Liu B; Li J; Zheng M; Ge J; Li J; Yu P
    Life Sci; 2017 Nov; 188():87-95. PubMed ID: 28866101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
    Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
    Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
    Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P
    Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
    Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
    Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-141-3p functions as a tumor suppressor through directly targeting ZFR in non-small cell lung cancer.
    Li W; Cui Y; Wang D; Wang Y; Wang L
    Biochem Biophys Res Commun; 2019 Feb; 509(3):647-656. PubMed ID: 30611568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1.
    Li J; Feng Q; Wei X; Yu Y
    Tumour Biol; 2016 Nov; 37(11):15221-15228. PubMed ID: 27683057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation Of microRNA-133b And Its Clinical Value In Non-Small Cell Lung Cancer.
    Chen GY; Ruan L
    Onco Targets Ther; 2019; 12():9421-9434. PubMed ID: 31807021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Downregulation of miRNA-126-3p is associated with progression of and poor prognosis for lung squamous cell carcinoma.
    Chen SW; Lu HP; Chen G; Yang J; Huang WY; Wang XM; Huang SP; Gao L; Liu J; Fu ZW; Chen P; Zhai GQ; Luo J; Li XJ; Huang ZG; Li ZY; Gan TQ; Yang DP; Mo WJ; Zhou HF
    FEBS Open Bio; 2020 Aug; 10(8):1624-1641. PubMed ID: 32598517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
    Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
    Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical value of miR-452-5p expression in lung adenocarcinoma: A retrospective quantitative real-time polymerase chain reaction study and verification based on The Cancer Genome Atlas and Gene Expression Omnibus databases.
    Gan XN; Luo J; Tang RX; Wang HL; Zhou H; Qin H; Gan TQ; Chen G
    Tumour Biol; 2017 May; 39(5):1010428317705755. PubMed ID: 28488527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
    Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic and epigenetic silencing of mircoRNA-506-3p enhances COTL1 oncogene expression to foster non-small lung cancer progression.
    Guo S; Yang P; Jiang X; Li X; Wang Y; Zhang X; Sun B; Zhang Y; Jia Y
    Oncotarget; 2017 Jan; 8(1):644-657. PubMed ID: 27893417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.